Columnist: 5 ways industry can help the FDA improve

10/12/2011 | Xconomy

The FDA may need some support from the biotech and drug sectors as the agency seeks to improve its processes for reviewing medical products, writes Luke Timmerman in this column. Timmerman breaks down five ways that the industry can take part in restoring public confidence in the agency, including showing support for an FDA budget increase and banning advisory panel members with conflicts of interest.

View Full Article in:

Xconomy

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC